Lipitor, also known as atorvastatin, is a medication commonly prescribed to lower cholesterol levels and reduce the risk of heart disease. While it is generally considered safe and effective, like any medication, it carries potential risks and side effects. One possible side effect of Lipitor is liver damage.

According to the FDA, Lipitor and other statin drugs have been associated with rare cases of liver injury. These cases are usually reversible when the medication is discontinued. However, it is important to be aware of the warning signs of liver damage while taking Lipitor. These signs may include:

1. Yellowing of the skin or eyes (jaundice): This is a common symptom of liver damage and should be reported to a healthcare professional immediately.

2. Unexplained fatigue or weakness: If you experience persistent fatigue or weakness that cannot be attributed to other factors, it could be a sign of liver damage.

3. Loss of appetite: A sudden decrease in appetite or unexplained weight loss may indicate liver problems.

4. Abdominal pain or swelling: Pain or swelling in the abdominal area can be a sign of liver damage. It is important to note that abdominal pain can have many causes, so it is important to consult a healthcare professional for an accurate diagnosis.

5. Dark urine: Dark urine, especially if accompanied by pale stools, can be a sign of liver dysfunction.

If you experience any of these symptoms while taking Lipitor, it is important to consult your healthcare provider immediately. They can evaluate your condition and determine the appropriate course of action, which may include discontinuing Lipitor or further medical tests.

It is worth noting that the occurrence of liver damage with Lipitor is rare, and most people tolerate the medication well. However, it is always important to be aware of potential side effects and to report any concerning symptoms to your healthcare provider.

Sources:
[1] Drug Patent Watch. Lipitor. Retrieved from https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] FDA. FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs
[3] American Heart Association Journals. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Retrieved from https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.118.312782